To win the deep-tech race, India needs ‘General Innovation Rules’India is launching ambitious science initiatives. However, current financial rules designed for conventional procurement hinder R&D. A new ...
Could protein 'traffic jams' be the key to understanding aging and Alzheimer's? Here's what Stanford scientists claimStanford University researchers have identified a breakdown in the cell's protein production system as a key factor in brain aging and cogn...
Cipla is aiming for 40-50 global product filings in three years, says MD Achin GuptaCipla is charting its next growth phase with a strong focus on innovation, complex generics, and biosimilars. The company plans significant...
Innovation, biosimilars, complex generics to drive Cipla's growth: Achin Gupta, MD & Group CEOAs Cipla approaches its centenary, the company is redefining its strategy by prioritizing innovation to amplify revenues. With ambitions to...
RFK Jr. shocks big pharma, yanks $500 million from mRNA vaccine projects, including for Flu and COVIDUS Health Secretary Robert F. Kennedy Jr. stopped 22 vaccine projects. These projects used mRNA technology. The vaccines aimed to fight COV...
mRNA vaccine against tuberculosis shows efficacy in mice, results pave way for larger trialsAustralian researchers have developed a new mRNA vaccine for tuberculosis, showing effective results in mice. The vaccine enhances immunity...
Cipla makes additional investment in German mRNA biotechEthris' has four potential drugs under development pipeline, of which one is for treating uncontrolled asthma and three other for primary c...
Emcure and its subsidiary Gennova settle legal dispute with HDT Bio over mRNA technologyEmcure Pharmaceuticals and its subsidiary Gennova have resolved all legal disputes with US-based HDT Bio Corp. The parties have entered int...
Sanofi says it's back to the drawing board on mRNA flu vaccinesSanofi, one of the top global vaccine makers, has stated that the current mRNA technology used in COVID-19 vaccines is not effective agains...
Cancer vaccines are being developed using tech similar to that used for Covid shotsDecades before Covid vaccines, scientists had been working on messenger ribonucleic acid (mRNA) vaccines targeting cancer.
COVID-19 mRNA vaccines increase risk of cardiac-related death, says Florida Surgeon GeneralThe Florida Department of Health (Department) conducted an analysis through a self-controlled case series, which is a technique originally ...
DCGI approves indigenous mRNA Covid jab for emergency use in 18 yrs & aboveAbout 70 lakh doses of the vaccine have already been cleared by the government’s nodal Central Drug Laboratory (CDL) at Kasauli and it is e...
Biological E to get mRNA technology from WHO to make COVID-19VaccinesWHO along with its partners will work with the Indian government and BE to develop a roadmap and put in place the necessary training and su...
Chinese firm buys Canada mRNA Covid vaccine tech in $500 million dealWhile almost 1 billion people have been fully vaccinated in China, the country is still lacking an mRNA shot, with most of the population i...
A cure for cancer: After Covid vaccine, next mRNA miracle might be closer than you imagineThe new technology was not only lightning fast but also incredibly effective - mRNA Covid vaccines from both Moderna and Pfizer hit the bul...
Can the Pfizer or Moderna mRNA vaccines affect my genetic code?Both the Pfizer and Moderna vaccines are mRNA vaccines, which contain tiny fragments of the genetic material known as “messenger ribonuclei...
India's Biological E. to make Providence Therapeutics' mRNA COVID-19 vaccineProvidence will sell up to 30 million doses of its mRNA vaccine, PTX-COVID19-B, to Biological E., and will also provide the necessary techn...